Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H10N2O7P2.H2O |
Molecular Weight | 290.1049 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
InChI
InChIKey=FUXFIVRTGHOMSO-UHFFFAOYSA-N
InChI=1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H10N2O7P2 |
Molecular Weight | 272.0896 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:52:19 UTC 2023
by
admin
on
Fri Dec 15 15:52:19 UTC 2023
|
Record UNII |
6XC1PAD3KF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
543616
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-VATC |
QM05BA08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-ATC |
M05BB08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOMETA (AUTHORIZED: BONES, FRACTURE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
LIVERTOX |
1051
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID ACCORD (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA GENERICS (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-ATC |
M05BA08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID MEDAC (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA GENERICS (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NDF-RT |
N0000175579
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C2136
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EU-Orphan Drug |
Zoledronic acid
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C67439
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEOPOROSIS, MENOPAUSAL)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
374112
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID MYLAN (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C443
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2868
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
6XC1PAD3KF
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
DB00399
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
100000091548
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
Zoledronic Acid
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
ZOLEDRONIC ACID ACTAVIS (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002667/human_med_001722.jsp&mid=WC0b01ac058001d124 | ||
|
165800-06-6
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
SUB21645
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
77655
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | RxNorm | ||
|
C088658
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL924
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
3177
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
DTXSID10168029
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
ZOLEDRONIC ACID
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
1724827
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
121586
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
II-2
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
6XC1PAD3KF
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
46557
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
m11658
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
C1699
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |